| Traws Pharma, Inc. (TRAW) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 |
| Close Price of Common Stock | 1.60$ | 1.79$ | 1.10$ | 1.88$ | 1.47$ | 2.32$ | 8.83$ | 5.82$ | 0.45$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | 12,785,387$ | 14,303,652$ | 8,789,954$ | 13,279,999$ | 8,179,543$ | 11,771,193$ | 26,715,642$ | 147,157,350$ | 11,312,081$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | (10.62%) | 62.73% | (33.81%) | 62.36% | (30.51%) | (55.94%) | (81.85%) | 1,200.89% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 56.31% | 21.51% | (67.10%) | (90.98%) | (27.69%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 10,157,257 | | 9,067,774 | 7,131,151 | 7,069,148 | 5,075,390 | 3,650,731 | 3,025,554 | 25,306,509 | 21,085,935 | 840,251 | 21,003,409 | 20,977,625 | 20,969,559 | 20,925,992 | 20,925,992 | 20,895,563 | 20,895,563 | 20,895,563 | 20,890,563 | 15,781,040 | 15,767,492 | 12,396,219 | 11,611,829 | 174,177,448 | 167,416,070 | 111,167,352 | 8,197,462 | 5,998,524 | 5,895,004 | 5,674,220 | 5,674,220 | 85,111,774 | 19,426,163 | 718,078 | 9,851,164 | 9,851,164 | 6,772,659 | 6,759,895 | 6,759,895 | 2,740,615 | 27,401,035 | 2,546,419 | 23,683,976 | 21,743,873 | 21,703,173 | 21,703,173 | 21,692,240 | 21,673,486 |
| QoQ% | | | 27.16% | .88% | 39.28% | 39.02% | 20.66% | (88.04%) | 20.02% | 2,409.48% | (96.00%) | .12% | .04% | .21% | .00% | .15% | .00% | .00% | .02% | 32.38% | .09% | 27.20% | 6.76% | (93.33%) | 4.04% | 50.60% | 1,256.12% | 36.66% | 1.76% | 3.89% | .00% | (93.33%) | 338.13% | 2,605.30% | (92.71%) | .00% | 45.46% | .19% | .00% | 146.66% | (90.00%) | 976.06% | (89.25%) | 8.92% | .19% | .00% | .05% | .09% | .16% |
| YoY% | 43.68% | | 148.38% | 135.70% | (72.07%) | (75.93%) | 334.48% | (85.60%) | 20.64% | .56% | (95.99%) | .37% | .39% | .35% | .15% | .17% | 32.41% | 32.52% | 68.56% | 79.91% | (90.94%) | (90.58%) | (88.85%) | 41.65% | 2,803.67% | 2,739.97% | 1,859.17% | 44.47% | (92.95%) | (69.65%) | 690.20% | (42.40%) | 763.98% | 186.83% | (89.38%) | 45.73% | 259.45% | (75.28%) | 165.47% | (71.46%) | (87.40%) | 26.25% | (88.27%) | 9.18% | .33% | .30% | 1.10% | 1.34% | 730.57% |